Survival and determinants of response to third-line chemotherapy in sensitive recurrent ovarian cancer patients

Br J Cancer. 1999 Jan;79(2):373-4.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / mortality
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / mortality

Substances

  • Antineoplastic Agents